Haploidentical hematopoietic cell transplantation for mycosis fungoides/Sezary syndrome

Margaret Kelsey BaronDepartment of Internal Medicine, University of Utah, Salt Lake City, UT, USA;

James Dane OsbornDivision of Hematology and Hematologic Malignancies, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA;

Randa TaoDepartment of Radiation Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA

Catherine J. LeeDivision of Hematology and Hematologic Malignancies, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA; Correspondence[email protected]

http://orcid.org/0000-0003-2587-8955

References

Agar NS, Wedgeworth E, Crichton S, et al. Survival outcomes and prognostic factors in mycosis fungoides/Sezary syndrome: validation of the revised international society for cutaneous lymphomas/European Organisation for Research and Treatment of Cancer staging proposal. J Clin Oncol. 2010;28:4730–4739.
PubMed Web of Science ®Google Scholar
Gragert L, Williams E, Eapen M, et al. HLA match likelihoods for hematopoietic stem-cell grafts in the U.S. Registry. N Engl J Med. 2014;371:339–348.
PubMed Web of Science ®Google Scholar
Ciurea SO, Zhang M, Bacigalupo AA, et al. Haploidentical transplant with postransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia. Blood. 2015;126:1033–1040.
PubMed Web of Science ®Google Scholar
Rashidi A, Hamadani M, Zhang M, et al. Outcomes of haploidentical vs matched sibling transplantation for acute myeloid leukemia in first complete remission. Blood Adv. 2019;3:1826–1836.
PubMed Web of Science ®Google Scholar
Méchineaud M, Mercier M, Le Corre Y, et al. Cutaneous and systemic T-cell lymphoma treated with haploidentical bone marrow transplantation. Ann Dermatol Venereol. 2018;145:439–444.
PubMed Web of Science ®Google Scholar
Duvic M, Donato M, Dabaja B, et al. Total skin electron beam and non-myeloablative allogeneic hematopoietic stem-cell transplantation in advanced mycosis fungoides and Sezary syndrome. J Clin Oncol. 2010;28:2365–2372.
PubMed Web of Science ®Google Scholar
Polansky M, Talpur R, Daulat S, et al. Long-term complete responses to combination therapies and allogeneic stem cell transplants in patients with Sezary syndrome. Clin Lymphoma Myeloma Leuk. 2015;15:83–93.
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Haploidentical hematopoietic cell transplantation for mycosis fungoides/Sezary syndrome

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Haploidentical hematopoietic cell transplantation for mycosis fungoides/Sezary syndrome

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date